The size of the North American Clinical Nutrition market was worth USD 4.79 Billion in 2021 and is estimated to be growing at a CAGR of 4.76% to reach USD 6.04 Billion by 2026. North America is the third-largest market for clinical nutrition products.
Clinical nutrition is an area of medicine that offers treatment of medical disorders initiated due to improper diet or the body’s failure to absorb nutrients accessible in a healthy diet. It is the most effective way to treat malnutrition and avoid associated costs. These products are considered the best alternatives for treating different diseases, such as kidney diseases, diabetes, cardiovascular diseases, and cancer.
Clinical nutrition spends are expected to increase due to the rise in the aged population. At old age, the digestive framework becomes weak and cannot digest all the required minerals by the body. Therefore, to get adequate supplements, the assurance of the aged population towards clinical nutrition support is developing.
The increasing prevalence of chronic disorders in North America is a major driver for growth. The majority of chronic disorders are caused by the body's inability to manufacture non-essential compounds such as vitamins, amino acids, and other nutrients. For example, diabetes is triggered by the consumption of food that has a high glycaemic index.
The patients are administrated to food with a low glycaemic index. A statistic suggests that 34.2 million adults have diabetes over 10.5 percent of the population, and this number is increasing day by day. Hence the demand for clinical food with a low glycaemic index tends to increase.
With high spending on healthcare, people are becoming more health-conscious. However, the demand for the nutrients from regular food is not completed properly, so people are more inclining towards clinical nutrition to satisfy the incomplete demand for nutrition.
With the increase in premature birth and malnutrition, a significant amount of nutrition is necessary for the child's growth, as over 149 million children are suffering from impaired growth and development. Therefore, clinical nutrition can be a great alternative.
However, the restraints allied with the clinical nutrition market include stringent regulations and a lack of awareness. The policies made by the government can be the barriers to the market growth of clinical nutrients in North America. In some areas, a lack of awareness about the clinical nutrients can also affect market growth. In addition, a reduced birth rate affects the demand for pediatric foods.
Impact of COVID-19 on the North American Clinical Nutrition Market:
Infection with COVID-19 has become a serious public health concern, and clinical nutrition can help prevent infection and treat infection-related malnutrition. The European Society for Clinical Nutrition and Metabolism, for example, has published nutritional therapy guidelines for COVID-19-infected ICU patients.
This research report on the North American clinical nutrition market has been segmented and sub-segmented into the following categories:
By Product Type:
By Therapeutic Areas:
By Ingredients Type:
By Country:
Geographically, the North American market is predicted to hold the most significant share in the global market during the forecast period. According to the American Society for Parenteral and Enteral Nutrition (ASPEN), 23.4 percent of parenteral products, such as multivitamin infusion, amino acids, potassium acetate injection, USP, sodium acetate injection, and sodium chloride, were in short supply as of January 2021.
In 2020, the U.S. Clinical Nutrition Market dominated the North American region. Growing consumer awareness about proper health and wellbeing is driving the market in this region. Growing geriatric population base, the growing burden of chronic diseases such as coronary artery disease, ischemic stroke, diabetes, few cancer indications are driving the growth of the U.S. clinical nutrition market. Moreover, the demand for medical nutrition therapy has increased due to the rising prevalence of diabetes in the United States. According to the International Diabetes Federation 2018, 34.2 million, or 10.5% of the total population, suffer from diabetics. Therefore, it is anticipated to raise the demand for medical nutrition therapy for diabetes, which will propel the growth of the U.S. clinical nutrition market.
The Canadian clinical nutrition market is expected to showcase a significant growth rate throughout the forecast period due to a tremendous birth rate, rising number of malnutrition patients receiving treatment, and a larger no. of premature births. Besides, the increasing prevalence of chronic disorders and an increase in the number of patients using advanced clinical nutritional products increase the market growth. In addition, the initiative was taken by the Canadian government authority to promote complete nutrition care is favoring the market. Furthermore, increased metabolic disorders, high disposable incomes, and improvement in patient awareness regarding the adoption of clinical nutrition products are expected to drive the Canadian clinical nutrition market further.
KEY MARKET PLAYERS:
Companies playing a dominant role in the North American clinical nutrition market profiled in this report are Nestle Nutrition, Abbott Laboratories Inc., Gentiva Health Services Inc., Mead Johnson & Company, Kendall, Ajinomoto Co. Inc., Hospira Inc., Hero Nutritionals Inc., Lonza Ltd, Baxter International Inc., B. Braun Melsungen AG, H. J. Heinz Company, American Home Patient Inc. and Fresenius Kabi.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Route of Administration
5.1.1 Oral Nutrition
5.1.2 Enteral Nutrition
5.1.3 Parenteral Nutrition
5.2 By Therapeutic Area
5.2.1 Malabsorption
5.2.2 Diarrhoea
5.2.3 Cancer
5.2.4 Food Allergies
5.2.5 Maldigestion
5.2.6 Diabetes
5.2.7 Short-Bowel Syndrome
5.2.8 Acute Lung Injury
5.2.9 Acute Respiratory Distress
5.3 By Ingredients Type
5.3.1 Vitamins
5.3.2 Minerals
5.3.3 Carbohydrates
5.3.4 Amino Acids
6. Geographical Analysis
6.1 Introduction
6.2 United States
6.3 Canada
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Nestle Nutrition
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Abbott Laboratories Inc.
8.3 Gentiva Health Services Inc.
8.4 Mead Johnson & Company
8.5 Kendall
8.6 Ajinomoto Co. Inc.
8.7 Hospira Inc.
8.8 Hero Nutritionals Inc.
8.9 Lonza Ltd
8.10 Baxter International Inc.
8.11 B. Braun Melsungen AG
8.12 H. J. Heinz Company
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Apr 2021
